Kai has broad experience leading strategic engagements with clients across the life sciences industry, including big and small pharma/biopharma companies and investors. He has worked in all the major therapeutic areas, with a deep expertise in oncology / immuno-oncology, ophthalmology, neurology, and rare diseases. Kai works across the product and organizational life cycle, with a specific interest in business development and licensing support, asset and therapeutic area strategy, and growth strategy. In partnering with clients, Kai works to bring a content-driven strategic perspective, driving to grounded and actionable recommendations.
Kai has 5+ years of experience in life sciences-related research and consulting. Prior to joining ClearView, Kai studied the mechanisms of cell division at Yale as well as bone regeneration at UCSF. He received his B.S. in molecular and cell biology from Yale.
Debbi Amanti Belanger